Darolutamide With Radium-223 or Placebo and the Effect on Radiological Progression-Free Survival for Patients With mCSPC

NCT05771896 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Bayer withdrew their support.

Conditions

Metastatic Prostate Cancer

Interventions

DRUG: Darolutamide
DRUG: Radium-223

Sponsor

GenesisCare USA

Collaborators

[object Object]